We recently published a list of 20 Most Expensive Stocks Insiders Are Dumping In March. In this article, we are going to take ...

Founded in 1996, Royalty Pharma is the largest buyer of biopharmaceutical royalties and a leading funder of innovation across the biopharmaceutical industry, collaborating with innovators from ...

Individual researchers and university leaders need to make the case for science to their elected representatives and to the public at large.

Russia may face a new wave of drugs’ shortages, particularly those, which are used for the treatment of rare diseases, as ...

For years, my son grew up as a perfectly healthy kid, despite being diagnosed with CF-related metabolic syndrome. But when he suddenly developed pancreatitis, I had a hunch it was actually related to ...

From today, the updated indication for TRIKAFTA is as follows: TRIKAFTA is indicated for the treatment of cystic fibrosis in patients aged 2 years and older who have at least one F508del mutation in ...

We recently published a list of 10 Best Diabetes Stocks To Buy According to Billionaires. In this article, we are going to ...

NSW Police Minister Yasmin Catley has told a parliamentary committee she is “not going to” reveal when she knew the Dural caravan was a hoax, despite the PM doing so. The Counterterrorism ...

In that case, it took seven years to get in 2012 to TRIKAFTA. I'm not saying it will happen that fast, but nonetheless, we did move quickly. And I think in this case, it feels just like 2012 to me.

Vertex's success since the early 2010s is due to its work in CF. The company famously markets the only approved medicines that target the underlying causes of this condition. Thanks to its monopoly, ...